Is DongKook Pharmaceutical stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, DongKook Pharmaceutical pays dividends. Last time was Friday 19th of April 2024 where the investors holding the stock on Wednesday 27th of December 2023 were paid KRW180 per share. Over the last 12 times between 2007 and 2023, DongKook Pharmaceutical has paid KRW14980.5 with an average of KRW1248.38 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for DongKook Pharmaceutical 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was KRW13 320, you would have made a profit of KRW3 340.00 per share or 25.08%
Yes, the average daily trading liquidity for DongKook Pharmaceutical is KRW234 585 thousand. You should therefore be able to get in and out of your positions relatively fast.
DongKook Pharmaceutical has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.49, the company's ability to pay off the debt is normal. DongKook Pharmaceutical has a good net profit margin of 6.80% and should have high tolerances against inflation.
We have calculated the inflation risk for DongKook Pharmaceutical to be low [0.4 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.